Combining rTMS with intensive language-action therapy in chronic aphasia: A randomized controlled trial

dc.contributorAalto-yliopistofi
dc.contributorAalto Universityen
dc.contributor.authorHeikkinen, Paula H.en_US
dc.contributor.authorPulvermüller, Friedemannen_US
dc.contributor.authorMäkelä, Jyrki P.en_US
dc.contributor.authorIlmoniemi, Risto J.en_US
dc.contributor.authorLioumis, Pantelisen_US
dc.contributor.authorKujala, Teijaen_US
dc.contributor.authorManninen, Riitta Leenaen_US
dc.contributor.authorAhvenainen, Anttien_US
dc.contributor.authorKlippi, Anuen_US
dc.contributor.departmentDepartment of Neuroscience and Biomedical Engineeringen
dc.contributor.organizationUniversity of Helsinkien_US
dc.contributor.organizationFree University of Berlinen_US
dc.contributor.organizationUniversity of Torontoen_US
dc.date.accessioned2019-06-20T13:17:16Z
dc.date.available2019-06-20T13:17:16Z
dc.date.issued2019-02-04en_US
dc.description.abstractNeuromodulation technologies, such as transcranial magnetic stimulation (TMS), are promising tools for neurorehabilitation, aphasia therapy included, but not yet in common clinical use. Combined with behavioral techniques, in particular treatment-efficient Intensive Language-Action Therapy (ILAT, previously CIAT or CILT), TMS could substantially amplify the beneficial effect of such behavioral therapy alone (Thiel et al., 2013; Martin et al., 2014; Mendoza et al., 2016; Kapoor, 2017). In this randomized study of 17 subjects with post-stroke aphasia in the chronic stage, we studied the combined effect of ILAT and 1-Hz placebo-controlled navigated repetitive TMS (rTMS) to the right-hemispheric inferior frontal cortex-that is, to the anterior part of the non-dominant hemisphere's homolog Broca's area (pars triangularis). Patients were randomized to groups A and B. Patients in group A received a 2-week period of rTMS during naming training where they named pictures displayed on the screen once every 10 s, followed by 2 weeks of rTMS and naming combined with ILAT. Patients in group B received the same behavioral therapy but TMS was replaced by sham stimulation. The primary outcome measures for changes in language performance were the Western Aphasia Battery's aphasia quotient AQ; the secondary outcome measures were the Boston naming test (BNT) and the Action naming test (Action BNT, ANT). All subjects completed the study. At baseline, no statistically significant group differences were discovered for age, post-stroke time or diagnosis. ILAT was associated with significant improvement across groups, as documented by both primary and secondary outcome measures. No significant effect of rTMS could be documented. Our results agree with previous results proving ILAT's ability to improve language in patients with chronic aphasia. In contrast with earlier claims, however, a beneficial effect of rTMS in chronic post-stroke aphasia rehabilitation was not detected in this study.en
dc.description.versionPeer revieweden
dc.format.mimetypeapplication/pdfen_US
dc.identifier.citationHeikkinen, P H, Pulvermüller, F, Mäkelä, J P, Ilmoniemi, R J, Lioumis, P, Kujala, T, Manninen, R L, Ahvenainen, A & Klippi, A 2019, 'Combining rTMS with intensive language-action therapy in chronic aphasia : A randomized controlled trial', Frontiers in Neuroscience, vol. 13, no. FEB, 1036. https://doi.org/10.3389/fnins.2018.01036en
dc.identifier.doi10.3389/fnins.2018.01036en_US
dc.identifier.issn1662-4548
dc.identifier.otherPURE UUID: eb4529d7-3efb-4f99-a398-26f9d7db37faen_US
dc.identifier.otherPURE ITEMURL: https://research.aalto.fi/en/publications/eb4529d7-3efb-4f99-a398-26f9d7db37faen_US
dc.identifier.otherPURE LINK: http://www.scopus.com/inward/record.url?scp=85065818936&partnerID=8YFLogxK
dc.identifier.otherPURE FILEURL: https://research.aalto.fi/files/34206160/fnins_12_01036.pdfen_US
dc.identifier.urihttps://aaltodoc.aalto.fi/handle/123456789/38889
dc.identifier.urnURN:NBN:fi:aalto-201906203955
dc.language.isoenen
dc.publisherFrontiers Media
dc.relation.ispartofseriesFrontiers in Neuroscienceen
dc.relation.ispartofseriesVolume 13, issue FEBen
dc.rightsopenAccessen
dc.subject.keywordChronic aphasiaen_US
dc.subject.keywordEfficacyen_US
dc.subject.keywordILATen_US
dc.subject.keywordLanguage rehabilitationen_US
dc.subject.keywordRandomized controlled trial (RCT)en_US
dc.subject.keywordRTMSen_US
dc.titleCombining rTMS with intensive language-action therapy in chronic aphasia: A randomized controlled trialen
dc.typeA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessäfi
dc.type.versionpublishedVersion

Files